Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
December 12, 2025
General
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
November 20, 2025
General
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference